Skip to main navigation Skip to search Skip to main content

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

  • OLIVES NGUYEN
  • , JACK WIEDRICK
  • , DANIELE MASSERA
  • , ELIZABETH ADLESTEIN
  • , SUMAR FREJAT
  • , MATTEO CASTRICHINI
  • , SAID ALSIDAWI
  • , JOHN R. GIUDICESSI
  • , JEFFREY B. GESKE
  • , RICHARD T. CARRICK
  • , JOSE MADRAZO
  • , NICOLE DELLISE
  • , MARK A. ZENKER
  • , THOMAS A. BOYLE
  • , NOSHEEN REZA
  • , ANJALI TIKU OWENS
  • , DAVID S. FRANKEL
  • , PRABHJOT HUNDAL
  • , JAMIL TAJIK
  • , PATRYCJA GALAZKA
  • MYRA LEWONTIN, MICHAEL AYERS, TIMOTHY WONG, MICHAEL FLANAGAN, SUMEET SINGH MITTER, ARJUN KANWAL, OZLEM BILEN, SARAH BAGHDADI, HIRAK SHAH, JARED KVAPIL, PAOLA ROLDAN, LOREN BERENBOM, JILL JESURUM, DENISE TOOTILL, ALICE SIQUEIRA-BENZOW, MARIKO HARPER, DANISH SALEH, LUBNA CHOUDHURY, ISABELA VALENTA, MELISSA LANG, DERMOT M. PHELAN, DMITRY PRIZAND, NEAL LAKDAWALA, CAROLYN Y. HO, LUSHA W. LIANG, SHEPARD D. WEINER, SRIRIAM RAVI, AHMED SAMI ABUZAID, MOHAMMED MAKKIYA, JEREMY S. MARKOWITZ, MARK SHERRID, AHMAD MASRI

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalJournal of cardiac failure
DOIs
StateAccepted/In press - 2026

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this